Trial intelligence / Profile preview

Effect of Local Anesthetic Infiltration for Postoperative Pain Control in Laparoscopic Abdominal Surgery

NCT07747584Not yet recruiting

Sponsor
Allied Hospital Faisalabad
Start
Aug 2026
Primary completion
Jan 2027
Countries
1
01

Overview

Randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Allied Hospital Faisalabad. Primary endpoint: Postoperative Pain Intensity at 24 hours. Planned start Aug 2026; status: not yet recruiting.

02

Drugs

bupivacaine hydrochloride 0.75% injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT07747584.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07747584.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call